Quick Takeaways
- This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
- 1 reported transaction and 3 derivative rows are listed below.
- Filing timestamp: 09 Jun 2021, 12:57.
Christopher Bunka - 08 Jun 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)
- Role
- CEO, Director
- Signature
- /Chris Bunka/
- Issuer symbol
- LEXX
- Transactions as of
- 08 Jun 2021
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 09 Jun 2021, 12:57:04 UTC
- Previous filing
- 09 Jun 2021
- Next filing
- 02 Sep 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 09 Jun 2021."
What Changed
- Previous filing in this sequence was filed on 09 Jun 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LEXX | common shares | 215,912 | 08 Jun 2021 | Private Holding Company | ||||||
| holding | LEXX | common shares | 273,543 | 08 Jun 2021 | Direct |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LEXX | Stock Options | Award | $0 | +23,334 | +71% | $0.000000 | 56,001 | 08 Jun 2021 | Common Shares | 23,334 | $7.08 | Direct | |
| holding | LEXX | Warrants | 6,667 | 08 Jun 2021 | Common Shares | 6,667 | $10.50 | Private Holding Company | ||||||
| holding | LEXX | Stock Options | 32,667 | 08 Jun 2021 | Common Shares | 26,000 | $5.83 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.